Skip to main content
. 2021 Dec 5;13(23):6129. doi: 10.3390/cancers13236129

Table 1.

Cohort characteristics by histology and sex.

Patients’ Characteristics Non-Squamous Squamous Unknown Histology Overall
n = 4393 (%)
n = 2793 n = 1559 n = 41
Women
n = 1057 (%)
Men
n = 1736 (%)
Women
n = 289 (%)
Men
n = 1270 (%)
Women
n = 13 (%)
Men
n = 28 (%)
Age at cohort entry date, mean (SD) 67.5 (11.5) 69.6 (9.7) 70.7(9.0) 71.8 (9.2) 68.9 (11.1) 70.6 (10.7) 69.8 (10.1)
Age bands at cohort entry date
18–54 144 (13.6) 136 (7.8) 17 (5.9) 67 (5.3) 2 (15.4) 4 (14.3) 370 (8.4)
55–69 424 (40.1) 671 (38.7) 100 (34.6) 395 (31.1) 3 (23.1) 6 (21.4) 1599 (36.4)
70–84 434 (41.1) 856 (49.3) 163 (56.4) 732 (57.6) 8 (61.5) 15 (53.6) 2208 (50.3)
85+ 55 (5.2) 73 (4.2) 9 (3.1) 76 (6.0) 0 3 (10.7) 216 (4.9)
Time in the study cohort,
median (IQR)
338.0
(113, 685)
211.0
(72, 533)
201.0
(70, 424)
228.0
(78, 444)
400.0
(140, 750)
134.0
(50, 370)
239.0
(80, 540)
First-line pharmacotherapies
Standard chemotherapy 526 (49.8) 921 (53.1) 151 (52.2) 694 (54.6) 6 (46.2) 13 (46.4) 2311 (52.6)
Target therapies 158 (14.9) 112 (6.5) 3 (1.0) 2 (0.2) 4 (30.8) 0 (0.0) 279 (6.4)
Immunotherapy 33 (3.1) 52 (3.0) 7 (2.4) 19 (1.5) 0 (0.0) 0 (0.0) 111 (2.5)
Unspecified anti-body therapy 10 (0.9) 23 (1.3) 1 (0.3) 12 (0.9) 0 (0.0) 0 (0.0) 46 (1.0)
Radiotherapy only 44 (4.2) 105 (6.0) 20 (6.9) 84 (6.6) 1 (7.7) 2 (7.1) 256 (5.8)
Untreated 286 (27.1) 523 (30.1) 107 (37.0) 459 (36.1) 2 (15.4) 13 (46.4) 1390 (31.6)
Concomitant radiotherapy 103 (9.7) 151 (8.7) 18 (6.2) 59 (4.6) 2 (15.4) 0 333 (7.6)
Diagnostic imaging
Computed tomography 745 (70.5) 1280 (73.7) 215 (74.4) 973 (76.6) 10 (76.9) 15 (53.6) 3238 (73.7)
Radiography 509 (48.2) 875 (50.4) 154 (53.3) 726 (57.2) 7 (53.8) 21 (75.0) 2292 (52.2)

SD: standard deviation; IQR: interquartile range.